24–25 Nov 2026
IARC
Europe/Paris timezone

Age-Specific Effects of Organized Mammography Screening Programs on Breast Cancer Mortality Across Varying Coverage: A Population-Based Comparative Study

T2-5
25 Nov 2026, 10:50
10m
RC 150 - Auditorium (IARC)

RC 150 - Auditorium

IARC

25 avenue Tony Garnier, Lyon, France
Short oral Cancer Screening, Early Detection & Health Systems Cancer Screening, Early Detection & Health Systems

Speaker

Meiwen Yuan (IARC)

Description

Aim
Evidence on organized mammography breast cancer screening (BCS) reflects mainly overall effects. We aim to estimate age-specific breast cancer mortality reductions attributable to BCS.
Methods
This population-based difference-in-differences study paired countries by similarity and screening initiation. The earlier-initiating country served as the screening country and the later-initiating country as the control. Pairs with significantly different pre-screening mortality trends (p ≤ 0.05) were excluded. Age-specific effects were estimated by comparing mortality changes between corresponding cohorts in each pair. The assumed log-linear coverage–effect relationship was evaluated using mean absolute error (MAE) and mean absolute percentage error (MAPE). Overall population-level effects were obtained by aggregating age-specific reductions using standard population weights.
Results
The UK–Ireland and Hungary–Poland pairs were eligible, with the UK and Hungary serving as screening countries. In the UK–Ireland pair (64% coverage), reductions increased with age from 9.6% (95% CI, −0.8% to 18.9%) at ages 55–59 to 38.9% (32.1%–45.0%) at ages 65–69, remaining substantial through age 79. Similar patterns were observed in Hungary–Poland (45% coverage). After rescaling coverage to 45%, modeled reductions from UK-Ireland closely matched observed reductions in Hungary–Poland (MAE, 0.017; MAPE, 6.1%). Modeled overall mortality reductions increased from 15.9% (95% CI, 10.9%–20.5%) at 45% coverage to 21.8% (15.1%–28.0%) at 64% and 31.9% (22.5%–40.1%) at 100%.
Conclusion
Breast cancer screening effectiveness depended primarily on coverage and lifetime screening duration. Age-specific estimates may inform assessments of progress toward the WHO Global Breast Cancer Initiative target.

Authors

Meiwen Yuan (IARC) Andrea Gini (IARC) Shuo Wang (Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China) Damien Georges (IARC) Yi Sum Irene Man (IARC) Giorgi Rossi Paolo (3 Epidemiology Unit, Azienda USL di Reggio Emilia — IRCCS, Reggio Emilia, Italy) Xuelian Zhao (Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China) Fanghui Zhao (Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China) Iacopo Baussano (IARC)

Presentation materials

There are no materials yet.